Lipella pharmaceuticals announces 1-for-8 reverse stock split

Pittsburgh, nov. 01, 2024 (globe newswire) -- lipella pharmaceuticals inc. (nasdaq: lipo) (the “company,” “our” or “us”), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that it intends to effect a 1-for-8 reverse stock split of its common stock effective as of 5:00 p.m. eastern time on november 7, 2024 upon the filing of a certificate of amendment to the company's certificate of incorporation with the secretary of state of the state of delaware.
LIPO Ratings Summary
LIPO Quant Ranking